Skip to content

Reward Processing and Depressive Subtypes: Identifying Neural Biotypes

Reward Processing and Depressive Subtypes: Identifying Neural Biotypes Related to Suicide Risk, Resilience, and Treatment Response

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06080646
Enrollment
158
Registered
2023-10-12
Start date
2021-06-01
Completion date
2025-09-01
Last updated
2026-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anhedonia, Depression, Depressive Disorder, Depressive Symptoms, Major Depressive Disorder, Major Depressive Episode

Keywords

reward, motivation, EEG, fMRI, MRI, functional MRI, amotivation, avolition, suicidality, suicide

Brief summary

Deficits in motivation and pleasure are common in depression, and thought to be caused by alterations in the ways in which the brain anticipates, evaluates, and adaptively uses reward-related information. However, reward processing is a complex, multi-circuit phenomenon, and the precise neural mechanisms that contribute to the absence or reduction of pleasure and motivation are not well understood. Variation in the clinical presentation of depression has long been a rule rather than an exception, including individual variation in symptoms, severity, and treatment response. This heterogeneity complicates understanding of depression and thwarts progress toward disease classification and treatment planning. Discovery of depression-specific biomarkers that account for neurobiological variation that presumably underlies distinct clinical manifestations is critical to this larger effort.

Detailed description

This study combines clinically motivated questions with in-depth study of neurobiological mechanisms to evaluate how reward system neurobiology contributes to expression of reward-related deficits, such as decreased pleasure and motivation in major depressive disorder (MDD). Conceptually, the investigator will use a multi-measure approach, by studying basic brain responses to reward anticipation as well as higher-order aspects of reward processing necessary for decision-making. Methodologically, the investigator will combine fMRI, EEG, and behavioral assessment, to more fully characterize reward-related brain functions and their clinical correlates. In addition to evaluating reward effects between MDD and healthy controls (HC), the investigator will also focus on understanding the relationship between reward processing and clinical features of high relevance to depression, with an emphasis on suicidality.

Interventions

n/a there is no intervention in this observational study

Sponsors

San Francisco Veterans Affairs Medical Center
Lead SponsorFED

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Our studies require some in-person visits to our research lab, located at 42nd Ave and Clement St in San Francisco. * Because this study includes an MRI, part of the screening process will be to ensure you don't have any metal in your body, you do not have head or neck tattoos, and you are comfortable inside the MRI scanner. Inclusion Criteria: * 18-70 years with a diagnosis of major depressive disorder (MDD) for MDD group, or without for unaffected comparison (UC) group * Negative metal screen for MRI safety * Normal (or corrected to normal) vision

Exclusion criteria

* Past or present neurological problems (including seizures and head trauma resulting in neurological or cognitive symptoms) * Loss of consciousness (LOC) greater than 30 minutes or any LOC with neurologic symptoms * Major medical conditions (e.g., seizure disorders, treatment with anticonvulsant medication, endocrine disorders, significant cardiac pathology) * Substance dependence, within the past year, or failed urine toxicology on the day of neuroimaging sessions * Known claustrophobia * Current Pregnancy * IQ estimate \< 70

Design outcomes

Primary

MeasureTime frameDescription
Stimulus preceding negativity1 month (EEG measure of reward anticipation)Stimulus preceding negativity (EEG measure of reward anticipation) of reward-related brain activation patterns and EEG responses on participants
Reward positivity1 month (EEG measure of reward feedback)Reward positivity (EEG measure of reward feedback) of reward-related brain activation patterns and EEG responses on participants
Late positive potential1 month (EEG measure of effective salience)Late positive potential (EEG measure of affective salience) of reward-related brain activation patterns and EEG responses on participants
fMRI response to win vs. loss reward feedback1 month (fMRI data)fMRI response to win vs. loss reward feedback of reward-related brain activation patterns and EEG responses on participants

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORSusanna L Fryer, PhD

University of California, San Francisco

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 9, 2026